Shattuck Labs, Inc. (STTK)

8.41 -0.07 (-0.83%) At close: 04:00PM EST

Shattuck Labs, Inc.

1018 West 11th Street
Suite 100
Austin, TX 78703
United States
919 864 2700
http://www.shattucklabs.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 59

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Taylor H. Schreiber M.D., Ph.D.	Co-Founder, CEO & Director	526.11k	N/A	1980
Dr. Arundathy Nirmalini Pandite M.B.A., M.D.	Chief Medical Officer	583k	N/A	1959
Ms. Casi DeYoung	Chief Bus. Officer	440.66k	N/A	1971
Mr. Andrew R. Neill M.B.A.	Chief Financial Officer	N/A	N/A	1986
Conor Richardson	Sr. Director of Fin. & Investor Relations	N/A	N/A	N/A
Dr. Abhinav A. Shukla Ph.D.	Chief Technical Officer	N/A	N/A	N/A
Ms. Erin Ator Thomson J.D.	Gen. Counsel	N/A	N/A	1980
Dr. Thomas Lampkin Pharm.D.	Head of Regulatory Affairs	N/A	N/A	N/A

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also holds a collaboration agreement with Takeda Pharmaceuticals to develop SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Corporate governance

Shattuck Labs, Inc.’s ISS governance QualityScore as of 26 September 2021 is 8. The pillar scores are Audit: 8; Board: 7; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.